» Articles » PMID: 39175956

Integrating Mechanism-based T Cell Phenotypes into a Model of Tumor-immune Cell Interactions

Overview
Journal APL Bioeng
Date 2024 Aug 23
PMID 39175956
Authors
Affiliations
Soon will be listed here.
Abstract

Interactions between cancer cells and immune cells in the tumor microenvironment influence tumor growth and can contribute to the response to cancer immunotherapies. It is difficult to gain mechanistic insights into the effects of cell-cell interactions in tumors using a purely experimental approach. However, computational modeling enables quantitative investigation of the tumor microenvironment, and agent-based modeling, in particular, provides relevant biological insights into the spatial and temporal evolution of tumors. Here, we develop a novel agent-based model (ABM) to predict the consequences of intercellular interactions. Furthermore, we leverage our prior work that predicts the transitions of CD8 T cells from a naïve state to a terminally differentiated state using Boolean modeling. Given the details incorporated to predict T cell state, we apply the integrated Boolean-ABM framework to study how the properties of CD8 T cells influence the composition and spatial organization of tumors and the efficacy of an immune checkpoint blockade. Overall, we present a mechanistic understanding of tumor evolution that can be leveraged to study targeted immunotherapeutic strategies.

References
1.
Petty A, Yang Y . Tumor-associated macrophages: implications in cancer immunotherapy. Immunotherapy. 2017; 9(3):289-302. PMC: 5619052. DOI: 10.2217/imt-2016-0135. View

2.
Ricketts T, Prieto-Dominguez N, Gowda P, Ubil E . Mechanisms of Macrophage Plasticity in the Tumor Environment: Manipulating Activation State to Improve Outcomes. Front Immunol. 2021; 12:642285. PMC: 8139576. DOI: 10.3389/fimmu.2021.642285. View

3.
Sica A, Larghi P, Mancino A, Rubino L, Porta C, Totaro M . Macrophage polarization in tumour progression. Semin Cancer Biol. 2008; 18(5):349-55. DOI: 10.1016/j.semcancer.2008.03.004. View

4.
Georgopoulou D, Callari M, Rueda O, Shea A, Martin A, Giovannetti A . Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response. Nat Commun. 2021; 12(1):1998. PMC: 8012607. DOI: 10.1038/s41467-021-22303-z. View

5.
West J, Robertson-Tessi M, Anderson A . Agent-based methods facilitate integrative science in cancer. Trends Cell Biol. 2022; 33(4):300-311. PMC: 10918696. DOI: 10.1016/j.tcb.2022.10.006. View